Treprostinil (Remodulin) for pulmonary arterial hypertension.
D018849:Controlled Clinical Trials as Topic; D004347:Drug Interactions; D011464:Epoprostenol / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007279:Injections, Subcutaneous; D009200:Myocardial Contraction; D010974:Platelet Aggregation / Q000187:drug effects; D014665:Vasodilator Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D014665:Vasodilator Agents; D011464:Epoprostenol; C427248:treprostinil